









Markets
/
Stocks
/
nasdaq-elmd
/

Electromed Inc

ELMD

24.340USD

-0.920-3.64%

Close 11/06, 16:00（ET）Quotes delayed by 15 min

203.22MMarket Cap

26.96P/E TTM



Electromed Inc

24.340

-0.920-3.64%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Electromed Inc

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Electromed Inc's Score

Industry at a Glance

Industry Ranking

60 / 210

Overall Ranking

151 / 4615

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Buy

Current Rating

35.000

Target Price

+38.56%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Electromed Inc Highlights

StrengthsRisks

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 33.15% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 64.00M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 64.00M.

Fairly Valued

The company’s latest PE is 27.30, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 4.37M shares, decreasing 3.35% quarter-over-quarter.

Financial Health

Currency: USD Updated: 2025-11-06

The company's current financial score is 9.43, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 17.39M, representing a year-over-year increase of 17.27%, while its net profit experienced a year-over-year increase of 20.57%.

Score

Industry at a Glance

Previous score

9.43

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.30

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.88

Key Metrics

Free cash flow

No Data

Electromed Inc's Company Valuation

Currency: USD Updated: 2025-11-06

The company’s current valuation score is 7.29, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 27.30, which is 101.52% below the recent high of 55.02 and 25.55% above the recent low of 20.32.

Score

Industry at a Glance

Previous score

7.29

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 60/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-06

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Electromed Inc is 35.50, with a high of 38.00 and a low of 31.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Buy

Current Rating

35.000

Target Price

+38.56%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Electromed Inc

ELMD

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-06

The company’s current price momentum score is 6.78, which is higher than the Healthcare Equipment & Supplies industry's average of 6.74. Sideways: Currently, the stock price is trading between the resistance level at 25.21 and the support level at 23.56, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.87

Change

-2.09

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.041

Neutral

RSI(14)

49.334

Neutral

STOCH(KDJ)(9,3,3)

61.216

Neutral

ATR(14)

0.682

High Vlolatility

CCI(14)

46.561

Neutral

Williams %R

58.182

Sell

TRIX(12,20)

-0.007

Sell

StochRSI(14)

19.967

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

24.528

Sell

MA10

24.398

Sell

MA20

24.499

Sell

MA50

24.537

Sell

MA100

22.128

Buy

MA200

23.531

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-06

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Craney (Stephen H)

600.50K

+2.14%

Winn (George H)

501.15K

-2.70%

The Vanguard Group, Inc.

Star Investors

435.64K

+20.21%

Radoff (Bradley Louis)

350.00K

-43.72%

BlackRock Institutional Trust Company, N.A.

300.67K

+804.83%

Summers Value Partners LLC

270.37K

-19.55%

Two Sigma Investments, LP

248.79K

+20.00%

Acadian Asset Management LLC

238.03K

-11.17%

Renaissance Technologies LLC

Star Investors

202.20K

+33.64%

Dimensional Fund Advisors, L.P.

189.41K

-13.00%

Risk Assessment

Currency: USD Updated: 2025-11-06

The company’s current risk assessment score is 3.79, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.26. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.